首页> 美国卫生研究院文献>The Journal of Biological Chemistry >Identification of Mixed Lineage Leukemia 1(MLL1) Protein as a Coactivator of Heat Shock Factor 1(HSF1) Protein in Response to Heat Shock Protein 90 (HSP90) Inhibition
【2h】

Identification of Mixed Lineage Leukemia 1(MLL1) Protein as a Coactivator of Heat Shock Factor 1(HSF1) Protein in Response to Heat Shock Protein 90 (HSP90) Inhibition

机译:响应热休克蛋白90(HSP90)抑制响应的混合谱系白血病1(MLL1)蛋白作为热休克因子1(HSF1)蛋白的共激活剂的鉴定。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Heat shock protein 90 (HSP90) inhibition inhibits cancer cell proliferation through depleting client oncoproteins and shutting down multiple oncogenic pathways. Therefore, it is an attractive strategy for targeting human cancers. Several HSP90 inhibitors, including AUY922 and STA9090, show promising effects in clinical trials. However, the efficacy of HSP90 inhibitors may be limited by heat shock factor 1 (HSF1)-mediated feedback mechanisms. Here, we identify, through an siRNA screen, that the histone H3 lysine 4 methyltransferase MLL1 functions as a coactivator of HSF1 in response to HSP90 inhibition. MLL1 is recruited to the promoters of HSF1 target genes and regulates their expression in response to HSP90 inhibition. In addition, a striking combination effect is observed when MLL1 depletion is combined with HSP90 inhibition in various human cancer cell lines and tumor models. Thus, targeting MLL1 may block a HSF1-mediated feedback mechanism induced by HSP90 inhibition and provide a new avenue to enhance HSP90 inhibitor activity in human cancers.
机译:热休克蛋白90(HSP90)抑制通过消耗客户的癌蛋白并关闭多个致癌途径来抑制癌细胞的增殖。因此,这是针对人类癌症的有吸引力的策略。几种HSP90抑制剂,包括AUY922和STA9090,在临床试验中显示出令人鼓舞的效果。但是,HSP90抑制剂的功效可能受到热休克因子1(HSF1)介导的反馈机制的限制。在这里,我们通过siRNA筛选确定组蛋白H3赖氨酸4甲基转移酶MLL1作为HSF1的共激活因子,响应HSP90抑制。 MLL1被募集到HSF1目标基因的启动子,并响应HSP90抑制来调节其表达。此外,当在各种人类癌细胞系和肿瘤模型中将MLL1耗竭与HSP90抑制作用相结合时,观察到了惊人的组合效果。因此,靶向MLL1可以阻断由HSP90抑制诱导的HSF1介导的反馈机制,并提供增强人类癌症中HSP90抑制剂活性的新途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号